ICL Acquires Lavie Bio to Enhance Biological Farming

ICL has acquired Lavie Bio, leveraging its microbiome-based technologies to enhance its crop input portfolio. This strategic move aims to accelerate innovation in sustainable agriculture, addressing the growing demand in the biologicals market, projected to expand at a 15% CAGR globally.

Original excerpt: ICL’s acquisition of Lavie Bio… poised to accelerate innovation and global adoption of sustainable ag solutions.

Source: Global Ag Tech Initiative